Knockdown of STAB1 inhibits AML cell line proliferation and growth in xenograft mice, possible via altering NF-κB pathway activity and has been suggested to increase AML cells sensitivity to venetoclax13,14. This evidence concerns the gene NFKB1 and acute myeloid leukemia.